Drug intelligence / Profile preview

fluoxetine + vitamin D3

Development stage
Unknown
Lead developer
Eli Lilly
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Metabolically Activated Prodrugs → Prodrugs/Conditional Activator Small Molecules → Small Molecules
Administration
Oral
01

Overview

Fluoxetine + vitamin D3 is a combination of two agents: fluoxetine, a selective serotonin reuptake inhibitor (SSRI) antidepressant, and vitamin D3 (cholecalciferol), a fat-soluble secosteroid involved in calcium homeostasis and bone metabolism. Fluoxetine acts by inhibiting the reuptake of serotonin in the central nervous system, thereby increasing serotonergic activity. Vitamin D3 is converted in the body to its active form, calcitriol, which binds to the vitamin D receptor to regulate gene expression related to calcium absorption and immune function. This combination has been studied as adjunctive therapy for major depressive disorder; clinical trials suggest that adding vitamin D3 to fluoxetine may enhance antidepressant efficacy compared with fluoxetine alone[2][10][9].

Other names
fluoxetine and cholecalciferolfluoxetine and vitamin D3
02

Targets

SERT (Sodium-dependent serotonin transporter)VDR (Vitamin D receptor)

Beyond the preview

Go deeper on fluoxetine + vitamin D3.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on fluoxetine + vitamin D3.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call